• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 3xTg-AD 小鼠中基因敲低脑源性神经营养因子不会改变 Aβ 或 tau 病理学。

Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology.

机构信息

Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, California, United States of America.

出版信息

PLoS One. 2012;7(8):e39566. doi: 10.1371/journal.pone.0039566. Epub 2012 Aug 3.

DOI:10.1371/journal.pone.0039566
PMID:22870188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3411687/
Abstract

Brain-derived neurotrophic factor (BDNF) is a neurotrophin critically involved in cell survival, synaptic plasticity, and memory. BDNF has recently garnered significant attention as a potential therapeutic target for neurodegenerative diseases such as Alzheimer disease (AD), but emerging evidence suggests that BDNF may also be mechanistically involved in the pathogenesis of AD. AD patients have substantially reduced BDNF levels, which may be a result of Aβ and tau pathology. Recent evidence, however, indicates reduced BDNF levels may also serve to drive pathology in neuronal cultures, although this has not yet been established in vivo. To further investigate the mechanistic role of BDNF in AD, we generated 3xTg-AD mice with a heterozygous BDNF knockout (BDNF(+/-)) and analyzed Aβ and tau pathology. Aged 3xTg-AD/BDNF(+/-) mice have significantly reduced levels of brain BDNF, but have comparable levels of Aβ and tau pathology to 3xTg-AD/BDNF(+/+) mice. These findings indicate that chronic reduction of BDNF does not exacerbate the development of Aβ and tau pathology, and instead suggests the reduced BDNF levels found in AD patients are a consequence of these pathologies.

摘要

脑源性神经营养因子(BDNF)是一种对细胞存活、突触可塑性和记忆至关重要的神经营养因子。BDNF 最近作为阿尔茨海默病(AD)等神经退行性疾病的潜在治疗靶点引起了广泛关注,但新出现的证据表明,BDNF 也可能在 AD 的发病机制中发挥作用。AD 患者的 BDNF 水平显著降低,这可能是由于 Aβ 和 tau 病理学的结果。然而,最近的证据表明,BDNF 水平降低也可能在神经元培养物中驱动病理学,尽管这尚未在体内得到证实。为了进一步研究 BDNF 在 AD 中的作用机制,我们生成了携带杂合 BDNF 敲除(BDNF(+/-))的 3xTg-AD 小鼠,并分析了 Aβ 和 tau 病理学。老年 3xTg-AD/BDNF(+/-) 小鼠的大脑 BDNF 水平显著降低,但与 3xTg-AD/BDNF(+/+) 小鼠相比,其 Aβ 和 tau 病理学水平相当。这些发现表明,BDNF 的慢性减少不会加剧 Aβ 和 tau 病理学的发展,而是表明 AD 患者中发现的 BDNF 水平降低是这些病理学的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dd9/3411687/770b03a9d29e/pone.0039566.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dd9/3411687/474b73ecd399/pone.0039566.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dd9/3411687/770b03a9d29e/pone.0039566.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dd9/3411687/474b73ecd399/pone.0039566.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dd9/3411687/770b03a9d29e/pone.0039566.g002.jpg

相似文献

1
Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology.在 3xTg-AD 小鼠中基因敲低脑源性神经营养因子不会改变 Aβ 或 tau 病理学。
PLoS One. 2012;7(8):e39566. doi: 10.1371/journal.pone.0039566. Epub 2012 Aug 3.
2
Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.钙通透性 TRPV1 疼痛受体敲除可挽救阿尔茨海默病小鼠模型的记忆缺陷,并减少淀粉样蛋白-β和 tau。
Hum Mol Genet. 2020 Jan 15;29(2):228-237. doi: 10.1093/hmg/ddz276.
3
Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.神经肽-1可改善阿尔茨海默病小鼠模型的学习和记忆缺陷,增加大脑中脑源性神经营养因子的表达,并减少β-淀粉样蛋白斑块。
Neurobiol Aging. 2014 May;35(5):990-1001. doi: 10.1016/j.neurobiolaging.2013.10.091. Epub 2013 Oct 29.
4
Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.成年 3xTg-AD 小鼠自发性自身免疫中的性别依赖性差异。
J Alzheimers Dis. 2018;63(3):1191-1205. doi: 10.3233/JAD-170779.
5
Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.神经营养肽能化合物慢性口服治疗对阿尔茨海默病三重转基因小鼠模型的疾病修饰作用。
Neurobiol Dis. 2014 Nov;71:110-30. doi: 10.1016/j.nbd.2014.07.001. Epub 2014 Jul 15.
6
Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.纤溶酶原激活物抑制剂-1 对脑源性神经营养因子剪切的调节作用导致阿尔茨海默病的神经病理学和认知缺陷。
Biochim Biophys Acta Mol Basis Dis. 2017 Apr;1863(4):991-1001. doi: 10.1016/j.bbadis.2017.01.023. Epub 2017 Jan 26.
7
Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.短期类现代生活应激会加剧3xTg-AD小鼠的Aβ病理和突触损失。
J Neurochem. 2015 Sep;134(5):915-26. doi: 10.1111/jnc.13195. Epub 2015 Jul 14.
8
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction.补充 3xTg-AD 小鼠的膳食锌可增加脑源性神经营养因子水平,预防认知功能障碍和线粒体功能障碍。
Cell Death Dis. 2010 Oct 28;1(10):e91. doi: 10.1038/cddis.2010.73.
9
Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice.敲除 5-脂氧合酶可预防地塞米松诱导的 3xTg 小鼠 tau 病理。
Aging Cell. 2013 Aug;12(4):706-11. doi: 10.1111/acel.12096. Epub 2013 Jun 11.
10
Soluble aβ promotes wild-type tau pathology in vivo.可溶性 aβ 在体内促进野生型 tau 病理。
J Neurosci. 2012 Nov 28;32(48):17345-50. doi: 10.1523/JNEUROSCI.0172-12.2012.

引用本文的文献

1
Harnessing BDNF Signaling to Promote Resilience in Aging.利用脑源性神经营养因子信号通路促进衰老过程中的恢复力。
Aging Dis. 2024 Nov 27. doi: 10.14336/AD.2024.0961.
2
The interaction of BDNF with estrogen in the development of hypertension and obesity, particularly during menopause.脑源性神经营养因子(BDNF)与雌激素在高血压和肥胖症发生发展过程中的相互作用,尤其是在绝经期间。
Front Endocrinol (Lausanne). 2024 Nov 25;15:1384159. doi: 10.3389/fendo.2024.1384159. eCollection 2024.
3
Age- and Sex-Associated Wnt Signaling Dysregulation is Exacerbated from the Early Stages of Neuropathology in an Alzheimer's Disease Model.

本文引用的文献

1
ST101 induces a novel 17 kDa APP cleavage that precludes Aβ generation in vivo.ST101 诱导一种新型的 17 kDa APP 切割,从而阻止体内 Aβ 的生成。
Ann Neurol. 2011 May;69(5):831-44. doi: 10.1002/ana.22325. Epub 2011 Mar 17.
2
Oligomeric amyloid-{beta} inhibits the proteolytic conversion of brain-derived neurotrophic factor (BDNF), AMPA receptor trafficking, and classical conditioning.寡聚淀粉样蛋白-β抑制脑源性神经营养因子(BDNF)的蛋白水解转化、AMPA 受体转运和经典条件反射。
J Biol Chem. 2010 Nov 5;285(45):34708-17. doi: 10.1074/jbc.M110.150821. Epub 2010 Aug 31.
3
Alzheimer's disease.
年龄和性别相关的 Wnt 信号失调在阿尔茨海默病模型的早期神经病理学阶段加剧。
Neurochem Res. 2024 Nov;49(11):3094-3104. doi: 10.1007/s11064-024-04224-7. Epub 2024 Aug 21.
4
Small extracellular vesicles: a novel drug delivery system for neurodegenerative disorders.小细胞外囊泡:一种用于神经退行性疾病的新型药物递送系统。
Front Aging Neurosci. 2023 Jun 19;15:1184435. doi: 10.3389/fnagi.2023.1184435. eCollection 2023.
5
GAP-43 closely interacts with BDNF in hippocampal neurons and is associated with Alzheimer's disease progression.生长相关蛋白43(GAP - 43)在海马神经元中与脑源性神经营养因子(BDNF)密切相互作用,并与阿尔茨海默病的进展相关。
Front Mol Neurosci. 2023 Apr 18;16:1150399. doi: 10.3389/fnmol.2023.1150399. eCollection 2023.
6
The effects of resistance exercise on cognitive function, amyloidogenesis, and neuroinflammation in Alzheimer's disease.抗阻运动对阿尔茨海默病认知功能、淀粉样蛋白生成及神经炎症的影响。
Front Neurosci. 2023 Mar 2;17:1131214. doi: 10.3389/fnins.2023.1131214. eCollection 2023.
7
Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential.阿尔茨海默病中的脑源性神经营养因子及其药物潜力。
Transl Neurodegener. 2022 Jan 28;11(1):4. doi: 10.1186/s40035-022-00279-0.
8
Optimized TrkB Agonist Ameliorates Alzheimer's Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase.优化的 TrkB 激动剂通过抑制 Delta- 分泌酶改善阿尔茨海默病病理和认知功能。
ACS Chem Neurosci. 2021 Jul 7;12(13):2448-2461. doi: 10.1021/acschemneuro.1c00181. Epub 2021 Jun 9.
9
Brain-Derived Neurotrophic Factor Signaling in the Pathophysiology of Alzheimer's Disease: Beneficial Effects of Flavonoids for Neuroprotection.脑源性神经营养因子信号在阿尔茨海默病发病机制中的作用:黄酮类化合物的神经保护有益作用。
Int J Mol Sci. 2021 May 27;22(11):5719. doi: 10.3390/ijms22115719.
10
Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.神经营养治疗在早期产后发育期间启动可预防类似阿尔茨海默病的行为和突触功能障碍。
J Alzheimers Dis. 2021;82(2):631-646. doi: 10.3233/JAD-201599.
阿尔茨海默病
N Engl J Med. 2010 Jan 28;362(4):329-44. doi: 10.1056/NEJMra0909142.
4
Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression.脑源性神经营养因子通过控制 SORLA 基因的表达减少淀粉样蛋白的生成。
J Neurosci. 2009 Dec 9;29(49):15472-8. doi: 10.1523/JNEUROSCI.3960-09.2009.
5
Dual response of BDNF to sublethal concentrations of beta-amyloid peptides in cultured cortical neurons.皮质神经元培养中β淀粉样肽亚致死浓度下 BDNF 的双重反应。
Neurobiol Dis. 2010 Jan;37(1):208-17. doi: 10.1016/j.nbd.2009.10.004. Epub 2009 Oct 12.
6
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.在阿尔茨海默病转基因模型中,神经干细胞通过脑源性神经营养因子改善认知。
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13594-9. doi: 10.1073/pnas.0901402106. Epub 2009 Jul 24.
7
Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis.BDNF Val66Met 多态性对阿尔茨海默病易感性的性别二态效应:新数据和荟萃分析。
Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):235-42. doi: 10.1002/ajmg.b.30986.
8
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease.脑源性神经营养因子在阿尔茨海默病啮齿动物和灵长类动物模型中的神经保护作用。
Nat Med. 2009 Mar;15(3):331-7. doi: 10.1038/nm.1912. Epub 2009 Feb 8.
9
Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.烟酰胺通过一种涉及抑制沉默调节蛋白和选择性降低苏氨酸231磷酸化tau蛋白的机制恢复阿尔茨海默病转基因小鼠的认知能力。
J Neurosci. 2008 Nov 5;28(45):11500-10. doi: 10.1523/JNEUROSCI.3203-08.2008.
10
NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons.神经生长因子(NGF)和脑源性神经营养因子(BDNF)信号通路控制海马神经元中的淀粉样蛋白生成途径和β-淀粉样蛋白(Aβ)的产生。
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13139-44. doi: 10.1073/pnas.0806133105. Epub 2008 Aug 26.